PH22020050135U1 - Anti-diabetes compositions comprising standardized mangifera indica extract - Google Patents

Anti-diabetes compositions comprising standardized mangifera indica extract

Info

Publication number
PH22020050135U1
PH22020050135U1 PH22020050135U PH22020050135U PH22020050135U1 PH 22020050135 U1 PH22020050135 U1 PH 22020050135U1 PH 22020050135 U PH22020050135 U PH 22020050135U PH 22020050135 U PH22020050135 U PH 22020050135U PH 22020050135 U1 PH22020050135 U1 PH 22020050135U1
Authority
PH
Philippines
Prior art keywords
mangifera indica
extract
standardized
ingredient
indica extract
Prior art date
Application number
PH22020050135U
Other versions
PH22020050135Y1 (en
Inventor
Bienvenido S Balotro
Razile Kay A Quibin
Raymond Fernando B Yu
Jowela B Alvarado
Rua Marie F Balanay
Joyce Katherine P Cotas
Original Assignee
Univ Of The Philippines Manila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of The Philippines Manila filed Critical Univ Of The Philippines Manila
Priority to PH22020050135U priority Critical patent/PH22020050135U1/en
Publication of PH22020050135Y1 publication Critical patent/PH22020050135Y1/en
Publication of PH22020050135U1 publication Critical patent/PH22020050135U1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present utility model concerns anti-diabetes compositions comprising standardized pharmaceutical-grade Mangifera indica extract as active ingredient. Particularly, the present utility model concerns a composition of Mangifera indica tablet dosage form comprising Mangifera indica extract; diluent ingredient; disintegrant ingredient; flow activator; and adsorbent ingredient; wherein the Mangifera indica extract comprises at least 70 pcnt ethanolic extract of Mangifera indica.
PH22020050135U 2020-05-04 2020-05-04 Anti-diabetes compositions comprising standardized mangifera indica extract PH22020050135U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH22020050135U PH22020050135U1 (en) 2020-05-04 2020-05-04 Anti-diabetes compositions comprising standardized mangifera indica extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH22020050135U PH22020050135U1 (en) 2020-05-04 2020-05-04 Anti-diabetes compositions comprising standardized mangifera indica extract

Publications (2)

Publication Number Publication Date
PH22020050135Y1 PH22020050135Y1 (en) 2021-02-03
PH22020050135U1 true PH22020050135U1 (en) 2021-02-03

Family

ID=74551198

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22020050135U PH22020050135U1 (en) 2020-05-04 2020-05-04 Anti-diabetes compositions comprising standardized mangifera indica extract

Country Status (1)

Country Link
PH (1) PH22020050135U1 (en)

Also Published As

Publication number Publication date
PH22020050135Y1 (en) 2021-02-03

Similar Documents

Publication Publication Date Title
NO20062513L (en) Compositions and dosage forms for enhanced absorption of metformin
NO20071667L (en) A pharmaceutical composition comprising levetiracetam and a process for the preparation of the composition
YU86001A (en) Novel preparation and administration form comprising an acid-labile active compound
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
CR9767A (en) COMPOSITION INCLUDING A CHOLESTEROL ABSORPTION INHIBITOR A HMG-COA INHIBITOR AND A STABILIZING AGENT Divisional application 7658
SE0001899D0 (en) New compounds
NO20080248L (en) Tablet containing insoluble active ingredient
PT2178513E (en) Tableted compositions containing atazanavir
MX2009013504A (en) Tableted compositions containing atazanavir.
MY147373A (en) Piperazine derivatives as antimalarial agents
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
WO2005065639A3 (en) Novel pharmaceutical compositions
PH22020050135U1 (en) Anti-diabetes compositions comprising standardized mangifera indica extract
MY153109A (en) A solid pharmaceutical formulation
DK0744947T3 (en) Modified release metronidazole preparations and methods for their preparation and use
MX2025012133A (en) Thiadiazolone derivatives, compositions and uses thereof
MX2024001889A (en) Deuterated compounds.
CN102204557A (en) Thiophanatemethyl and polyoxin antibacterial composition
DK1765342T3 (en) Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for the preparation thereof
PH22020050133U1 (en) Anti-inflammatory compositions comprising standardized curcuma longa extract
BG109404A (en) Deramciclane-fumarate tablets
PH22020050130Y1 (en) Compositions comprising standardized orthosiphon aristatus extract
DE502004007298D1 (en) ORAL FORM FOR APPLICATION FOR HEAVY ACID AND AMPHOTERE ACTIVE SUBSTANCES
BR0001144B1 (en) PHARMACEUTICAL COMPOSITION OF VITAMIN-E, PAPAINE AND HYALURONIDASE-BASED DICLOPHENAC
PH22020050132Y1 (en) Compositions comprising standardized ocimum sanctum leaf powder